Showing 5761-5770 of 7126 results for "".
- Business News: Lilly, Dermira Acquisition Completehttps://practicaldermatology.com/news/business-news-lilly-dermira-acquisition-complete/2460287/Eli Lilly and Company has completed its acquisition of Dermira, Inc. The acquisition expands Lilly's immunology pipeline with the addition of lebrikizumab, a novel, investigational, monoclonal antibody designed to bind IL-13 that is being evaluated in a Phase 3 clinical development
- Sun Pharma Survey: Impact of Psoriasis on Patients is Extensivehttps://practicaldermatology.com/news/sun-pharma-survey-impact-of-psoriasis-on-patients-is-extensive/2460284/The impact of moderate-to-severe plaque psoriasis on social and personal interactions can be extensive, results of a new survey from Sun Pharma confirm. In fact, 44 percent of respondents said that they often or sometimes feel humiliated by the appearance of psoriasis. More than a quarter (28 per
- Western Diet Linked to Skin Inflammation, Psoriasishttps://practicaldermatology.com/news/western-diet-linked-to-skin-inflammation-psoriasis/2460283/The Westernized diet, characterized by a high dietary intake of saturated fats and sucrose and low intake of fiber, may lead to inflammatory skin diseases such as psoriasis, a study by UC Davis Health researchers has found. The
- Revance: FDA Accepts BLA for DaxibotulinumtoxinA, Sets November PDUFA Datehttps://practicaldermatology.com/news/revance-fda-accepts-bla-for-daxibotulinumtoxina-sets-november-pdufa-date/2460278/FDA has accepted the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar (frown) lines, Revance reports. The FDA set an action date of November 25, 2020 under the Prescription Drug User Fee Act (PDUFA) VI program.
- Resident of Distinction Award Celebrates 10th Anniversary at 2020 Caribbean Dermatology Symposiumhttps://practicaldermatology.com/news/resident-of-distinction-award-celebrates-10th-anniversary-at-2020-caribbean-dermatology-symposium/2460276/As part of the dermMentors Resident of Distinction Award, Beiersdorf Inc. sponsored five top dermatology residents to attend the 2020 Caribbean Dermatology Symposium, held in Paradise Island, Bahamas, from Jan. 21-25, 2020.
- Mattel Releases New Barbie Dolls with Vitiligo, Alopeciahttps://practicaldermatology.com/news/mattel-releases-new-barbie-dolls-with-vitiligo-alopecia-1/2460268/In an effort to be more inclusive, Mattel, the maker of Barbie dolls, has released new dolls in its Fashionista line including a Barbie with alopecia and one with vitiligo. “For 2020, Barbie is continuing the journey to represent global diversity and inclusivity in the f
- BioPharmX Corporation and Timber Pharmaceuticals LLC Announce Mergerhttps://practicaldermatology.com/news/biopharmx-corporation-and-timber-pharmaceuticals-llc-announce-merger/2460267/BioPharmX Corporation and Timber Pharmaceuticals LLC have entered into a definitive merger agreement. Under the terms of the merger agreement, subject to the approval of BioPharmX's stockholders and Timber's members, a wholly-owned subsidiary of BioPharmX will be merged wit
- Survey: Many Men Don’t Wash Their Faces Every Dayhttps://practicaldermatology.com/news/survey-many-men-dont-wash-their-faces-every-day/2460266/One-third of men admit to not washing their faces daily, according to a poll of 1,000 men aged 18 and older conducted by AcuPoll for Tiege Hanley. The Men’s Skin Care Survey by Tiege Hanley found that younger men are more likely to drop the
- Alma Rolls Out Opus Plasmahttps://practicaldermatology.com/news/alma-rolls-out-opus-plasma/2460264/Alma, Inc. is launching Opus in North America. Opus is a new platform featuring the company's proprietary high-frequency unipolar radio-frequency technology, Opus Plasma. Opus Plasma is the first fractional plasma technology to enter the f
- Cynosure Taps Todd Tillemans As New CEOhttps://practicaldermatology.com/news/cynosure-taps-todd-tillemans-as-new-ceo-2/2460262/Todd Tillemans is the new Chief Executive Officer of Cynosure, LLC. Mr. Tillemans is the former President of Hershey's flagship U.S. business generating more than $6.5 billion in annual sales. Prior to that, he held various leadership positions across Unilever's